The association of timing of disease-modifying drug initiation and relapse in patients with multiple sclerosis using electronic health records

2017 ◽  
Vol 33 (6) ◽  
pp. 1127-1132 ◽  
Author(s):  
Frank A. Corvino ◽  
David Oliveri ◽  
Amy L. Phillips
2021 ◽  
Vol 8 (4) ◽  
pp. 800-810
Author(s):  
Yuri Ahuja ◽  
Nicole Kim ◽  
Liang Liang ◽  
Tianrun Cai ◽  
Kumar Dahal ◽  
...  

2019 ◽  
Vol 26 (14) ◽  
pp. 1948-1952 ◽  
Author(s):  
Farren BS Briggs ◽  
Eddie Hill

Background/objective: In 2019, the 2010 U.S. multiple sclerosis (MS) prevalence was robustly estimated (265.1–309.2/100,000) based on large administrative health-claims datasets. Using 56.6 million electronic health records (EHRs), we sought to generate complementary age, sex, and race standardized estimates. Methods/results: Using de-identified EHRs and 2018 U.S. Census data, we estimated an age- and sex-standardized MS prevalence of 219.5/100,000 which increased to 274.5/100,000 when accounting for White and Black race alone. Women aged 50 to 69 years had the highest prevalence (>600/100,000). Among White and Black Americans, the age- and sex-standardized prevalence was 283.7 and 226.1 per 100,000, respectively. Conclusion: Using 56.6 million EHRs and standardizing for age, sex, and race (White and Black Americans only), we estimated at least 810,504 Americans were living with MS in 2018.


PLoS ONE ◽  
2013 ◽  
Vol 8 (11) ◽  
pp. e78927 ◽  
Author(s):  
Zongqi Xia ◽  
Elizabeth Secor ◽  
Lori B. Chibnik ◽  
Riley M. Bove ◽  
Suchun Cheng ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document